Atlas Trials

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

Clinical trial NCT00163618 · COMPLETED

Trial details

NCT number
NCT00163618
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Encephalitis, Tick-borne
Start date
2005-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.